Theriva Biologics holds annual shareholder meeting
TOVX•Shareholders approve plan and charter changes
Theriva Biologics held its annual shareholder meeting on Aug. 3, 2026.
Shareholders backed a change to the 2020 Stock Incentive Plan, raising the share pool to 6,500,000 from 4,500,000.
An amendment to increase authorized common shares cleared; the board can still choose whether to file the charter amendment.
Investors ratified BDO USA as independent auditor for the year ending Dec. 31, 2026.
Holders also authorized common share issuance on warrant exercise, while a contingency proposal to adjourn the meeting was approved but not used.
